-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PNBk3QJ12IY/tEoW2BCJH4gji+YRYwzwGDCw9acey7eV84Kco9QnQUf3vsSaaCxU oy3TFKODkJsjqrqDsL6oJA== 0000950123-10-050656.txt : 20100518 0000950123-10-050656.hdr.sgml : 20100518 20100518082602 ACCESSION NUMBER: 0000950123-10-050656 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100514 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20100518 DATE AS OF CHANGE: 20100518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 10841137 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 8-K 1 l39801e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 14, 2010
MYLAN INC.
(Exact Name of Registrant as Specified in Charter)
         
Pennsylvania   1-9114   25-1211621
(State or Other Jurisdiction of
Incorporation) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
     
1500 Corporate Drive
Canonsburg, PA
(Address of Principal Executive Offices) 		  15317
(Zip Code)
Registrant’s telephone number, including area code: (724) 514-1800
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
 

 

 

Item 5.07.   Submission of Matters to a Vote of Security Holders.
     The 2010 Annual Meeting of Shareholders of Mylan Inc. (“Mylan” or the “Company”) was held on May 14, 2010 to (i) elect nine members of the Board of Directors for one year terms; (ii) ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm; (iii) consider a shareholder proposal related to an advisory (non-binding) vote on executive compensation; and (iv) consider a shareholder proposal related to retention of executive equity compensation. For more information about the foregoing proposals, see Mylan's proxy statement dated April 5, 2010, the relevant portions of which are incorporated herein by reference. As of March 25, 2010, the record date for the Annual Meeting, there were 308,257,273 shares of common stock outstanding and entitled to vote. At the Annual Meeting, 262,225,956 shares of common stock were represented in person or by proxy, constituting a quorum. The certified results of the matters voted on at the Annual Meeting are set forth below.
     Proposal No. 1 — Election of Nine Directors.
                 
Nominee   For   Withheld
 
                
Robert J. Coury
     207,409,178       13,806,147  
Rodney L. Piatt
     207,619,606       13,595,718  
Wendy Cameron
     208,572,722       12,642,603  
Neil Dimick
     202,300,189       18,915,136  
Douglas J. Leech
     207,178,712       14,036,613  
Joseph C. Maroon, M.D.
     209,201,811       12,013,514  
Mark W. Parrish
     216,263,895       4,951,430  
C.B. Todd
     215,620,164       5,595,161  
Randall L. Vanderveen, Ph.D.
     216,418,280       4,797,044  
     Proposal No. 2 — Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2010.
             
For   Against   Abstain   Broker Non-Votes
 
259,033,603
  2,293,326   896,127   0
     Proposal No. 3 — Consideration of a shareholder proposal on advisory (non-binding) votes on executive compensation.
             
For   Against   Abstain   Broker Non-Votes
 
108,016,311   110,378,403   2,817,188   41,014,054
     Proposal No. 4 — Consideration of a shareholder proposal on share retention by executives following separation from employment.
             
For   Against   Abstain   Broker Non-Votes
 
75,169,031   144,320,361   1,723,010   41,013,554

 

 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MYLAN INC.
 		  
Date: May 18, 2010  By:   /s/ John D. Sheehan    
    John D. Sheehan   
    Executive Vice President and Chief Financial Officer   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----